We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.19%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$24B
AUM Growth
-$8.57B
(-26%)
Cap. Flow
-$8.5B
Cap. Flow
% of AUM
-35.37%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
5,150
New
660
Increased
1,270
Reduced
2,242
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Amazon
AMZN
|
+$264M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$138M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Doximity
DOCS
|
+$72.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
| 2 |
Intuitive Surgical
ISRG
|
+$110M |
| 3 |
Boston Scientific
BSX
|
+$96.4M |
| 4 |
Cummins
CMI
|
+$90.4M |
| 5 |
Microsoft
MSFT
|
+$77.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.1% |
| 2 | Consumer Discretionary | 7.52% |
| 3 | Industrials | 5.58% |
| 4 | Financials | 4.45% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CoStar Group
CSGP
$11.3B
| $21.7M | 0.09% |
536,787
+504,325
| +1,554% | +$26.3M |
|
152
CALL
Gilead Sciences
GILD
$161B
| $21.6M | 0.09% |
155,300
-29,300
| -16% | -$4.1M |
|
153
Salesforce
CRM
$134B
| $21.6M | 0.09% |
115,834
-154,292
| -57% | -$32M |
|
154
PUT
Johnson & Johnson
JNJ
$635B
| $21.6M | 0.09% |
88,300
-167,200
| -65% | -$38.9M |
|
155
ExxonMobil
XOM
$651B
| $21.5M | 0.09% |
126,912
-50,248
| -28% | -$7.33M |
|
156
ATI
ATI
$27B
| $21.3M | 0.09% |
146,109
+43,811
| +43% | +$6.1M |
|
|
NVO
157
Novo Nordisk
NVO
$216B
| $21.3M | 0.09% |
578,309
+77,665
| +16% | +$3.68M |
|
158
CALL
Bank of America
BAC
$435B
| $21.2M | 0.09% |
434,600
+179,900
| +71% | +$9.28M |
|
159
Thermo Fisher Scientific
TMO
$211B
| $21.2M | 0.09% |
43,039
+28,793
| +202% | +$15.6M |
|
160
Capri Holdings
CPRI
$1.77B
| $21.1M | 0.09% |
1,200,078
+273,743
| +30% | +$5.79M |
|
161
CALL
Tesla
TSLA
$1.24T
| $21.1M | 0.09% |
56,800
-57,700
| -50% | -$23.8M |
|
|
162
Gilead Sciences
GILD
$161B
| $21M | 0.09% |
150,967
+127,817
| +552% | +$17.9M |
|
163
Merck
MRK
$324B
| $21M | 0.09% |
174,672
+83,898
| +92% | +$9.69M |
|
164
Advance Auto Parts
AAP
$3.37B
| $21M | 0.09% |
398,097
+132,842
| +50% | +$6.65M |
|
165
Meritage Homes
MTH
$4.87B
| $20.9M | 0.09% |
337,519
-138,480
| -29% | -$9.79M |
|
166
Watts Water Technologies
WTS
$11.5B
| $20.8M | 0.09% |
71,800
+7,719
| +12% | +$2.35M |
|
167
Jabil
JBL
$32.8B
| $20.8M | 0.09% |
78,464
-122,108
| -61% | -$30.8M |
|
168
Southern Company
SO
$110B
| $20.8M | 0.09% |
215,732
+214,413
| +16,256% | +$19.8M |
|
169
GSK
GSK
$103B
| $20.6M | 0.09% |
373,096
+321,192
| +619% | +$17.4M |
|
170
BioMarin Pharmaceuticals
BMRN
$11.5B
| $20.6M | 0.09% |
364,246
+141,779
| +64% | +$8.27M |
|
171
Celestica
CLS
$35.1B
| $20.5M | 0.09% |
72,648
+7,209
| +11% | +$2.09M |
|
172
HF Sinclair
DINO
$15.9B
| $20.5M | 0.09% |
327,778
+107,332
| +49% | +$5.82M |
|
|
173
CALL
Amazon
AMZN
$2.5T
| $20.4M | 0.08% |
98,000
-73,600
| -43% | -$16.2M |
|
174
Apollo Global Management
APO
$70.7B
| $20.2M | 0.08% |
181,701
+97,013
| +115% | +$12M |
|
175
PUT
UnitedHealth
UNH
$382B
| $20.2M | 0.08% |
74,600
-17,000
| -19% | -$5.06M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Walleye Capital held 5,150 positions worth $24B, down 26% from $32.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Walleye Capital withdrew a net $8.5B in Q1 2026, closing 835 positions and reducing 2,242 holdings. Its most notable exit was Repligen, an estimated $68.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 7.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Walleye Capital opened a new position in Texas Roadhouse worth $51.4M.
- Walleye Capital's largest Q1 2026 buy was Texas Roadhouse: 311,416 shares worth $51.4M.
- Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $948M increase.
- Walleye Capital's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $778M.
- Walleye Capital fully exited Repligen in Q1 2026, selling an estimated $68.3M.
- Walleye Capital's ten largest holdings make up 33% of its $24B portfolio in Q1 2026.
- Walleye Capital opened 660 new positions and closed 835 in Q1 2026.
- Walleye Capital's portfolio value fell 26% quarter-over-quarter to $24B.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.